Not applicableUnknownNCT03648671What this trial is testingPain in Parkinson's Disease With Motor Fluctuations.Who this might be right forParkinson Disease Universita di Verona 48
Large-scale testing (Phase 3)Ended earlyNCT02153645What this trial is testingEfficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.Who this might be right forParkinson's DiseaseLevodopa Induced Dyskinesias (LID) Adamas Pharmaceuticals, Inc. 87
Large-scale testing (Phase 3)UnknownNCT02615873What this trial is testingAP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004Who this might be right forParkinson's Disease Intec Pharma Ltd. 460
Early research (Phase 1)Study completedNCT03496870What this trial is testingThe Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.Who this might be right forParkinson Disease Neurocrine Biosciences 16
Early research (Phase 1)Study completedNCT00415844What this trial is testingBioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy VolunteersWho this might be right forHealthy Novartis 42
Large-scale testing (Phase 3)Study completedNCT02337764What this trial is testingA Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease ParticipantsWho this might be right forParkinson's Disease Takeda 222
Early research (Phase 1)Study completedNCT01103011What this trial is testingSafety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611Who this might be right forParkinson's Disease NeuroDerm Ltd. 8
Post-approval studies (Phase 4)Looking for participantsNCT06316232What this trial is testingDBS and Levodopa for Treating Freezing of Gait in Parkinson's DiseaseWho this might be right forFreezing of GaitParkinson Disease IRCCS Istituto delle Scienze Neurologiche di Bologna 20
Post-approval studies (Phase 4)UnknownNCT06115538What this trial is testingComparison of Dopamin Level in Idiopathic Parkinson's PatientsWho this might be right forParkinson DiseaseTreatment Adherence Ankara Ataturk Sanatorium Training and Research Hospital 96
Testing effectiveness (Phase 2)UnknownNCT03576638What this trial is testingStudy to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease PatientsWho this might be right forParkinson Disease Intec Pharma Ltd. 12
Large-scale testing (Phase 3)Active Not RecruitingNCT03735901What this trial is testingEnhancement of Stroke Rehabilitation With LevodopaWho this might be right forAcute StrokeStroke Rehabilitation University Hospital, Basel, Switzerland 610
Testing effectiveness (Phase 2)Study completedNCT01211587What this trial is testingA Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's DiseaseWho this might be right forParkinson's Disease With Cognitive Impairments Newron Pharmaceuticals SPA 103
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07375693What this trial is testingEffect of Melatonin on Oxidative Stress Parameters in Levodopa-Treated Parkinson's Disease PatientsWho this might be right forParkinson Disease Bangladesh Medical University 70
Not applicableLooking for participantsNCT06772220What this trial is testingPilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's DiseaseWho this might be right forParkinson&Amp;#39;s Disease Oregon Health and Science University 150
Not applicableStudy completedNCT01956032What this trial is testingDuodopa Home Titration Using Telemedicine: Evaluation of Use of ResourcesWho this might be right forParkinson's Disease AbbVie 15
Testing effectiveness (Phase 2)Study completedNCT00888004What this trial is testingEfficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease PatientsWho this might be right forParkinson's DiseaseL-dopa Induced Dyskinesia Novartis 28
Testing effectiveness (Phase 2)WithdrawnNCT00451633What this trial is testingThe Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor FluctuationsWho this might be right forParkinson's Disease Eisai Inc.
Large-scale testing (Phase 3)Looking for participantsNCT07151378What this trial is testingIntestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's DiseaseWho this might be right forPARKINSON DISEASE (Disorder) University Hospital Tuebingen 150
Testing effectiveness (Phase 2)Study completedNCT01602549What this trial is testingAssess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric EmptyingWho this might be right forGastroparesis GlaxoSmithKline 58
Large-scale testing (Phase 3)Study completedNCT01468012What this trial is testingImaging the Neurobiology of Behavioral and Medication Treatment for Cocaine DependenceWho this might be right forCocaine Dependence New York State Psychiatric Institute 23